Increasing awareness about various allergies, the
introduction of the new treatment of products and rising demand from emerging
markets drives the growth of the global market. Drug allergy is one of the most
common types of allergies. It is the hyper sensitivity of the immune system to
drug or medication. Any types of drugs such as prescription, nonprescription or
herbal can induce drug allergy. Some common symptoms of the
drug allergies are hives, skin rash, itching of the eyes or skin, swelling of
the face, lips, or tongue, wheezing, and others. Treatment can relieve and
prevent severe reactions.
New research to prevent drug allergies is
another key driver for the market. The global drug allergy market is growing
moderately and is expected to continue its growth over the forecast period.
Reaction to drugs
and other medication can differ from patient to patient, with drug allergies
becoming increasingly common. Market Research Future (MRFR) in its latest
report has discovered that the market is due to witness a CAGR of 5.1% during
the forecast period of 2017 to 2023. MRFR has further ascertained that the drug
allergy market share is expected to grow to reach an estimated value of USD
4,764 Mn by the end of 2023
Top Key
Players
AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy
Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA
Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.
Segments
The global drug allergy market is segmented on the basis
of type, which comprises of immunologic, nonimmunologic, and others.
Immunologic allergy is sub-segmented into type I reaction, type II reaction,
type III reaction, type IV reaction, and others. The non-immunologic allergy is
sub-segmented into predictable, unpredictable, and others. The predictable
allergy is further segmented into pharmacologic side effect, secondary
pharmacologic side effect, drug toxicity, drug-drug interactions, drug
overdose, and others. The unpredictable segment is further sub-segmented into
pseudoallergic, idiosyncratic, intolerance, and others.
On the basis of diagnosis, the market is segmented into
skin tests, blood tests, patch test, and others. The skin test is further
segmented into prick or scratch test, intradermal test, and others.
On the basis of treatments, the market is segmented into
antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the
drug, and others. Antihistamines are further sub-segmented into azelastine
eyedrops, azelastine nasal sprays, carbinoxamine, cyproheptadine,
desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine
eyedrops, levocabastine oral, and others. Corticosteroids is further
sub-segmented into topical steroids, inhaled steroids, and others. Inhaled
steroids is further segmented into flunisolide, fluticasone furoate,
fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate,
budesonide, and others.
On the basis of end user, it is segmented into hospitals
& clinics, medical research centers, academic institutes, and others.
Regional
Analysis
The Americas dominate the global market for the drug
allergy. The Americas mainly include North America and Latin America, out of
which North America accounts for the majority of the market share of this
region. The US is the top revenue generating market in North America and is one
of the important markets for the global drug allergy treatment. Approximately
10% of the total US population have drug allergies. Latin America drug allergy
market is also growing significantly and mainly includes Brazil, Argentina, and
Chile. Europe is the second largest market in the globe owing to increasing
cases of drug allergy.
Europe is mainly divided into Eastern Europe and Western
Europe. More developed Western European countries like Germany, UK and France
are dominating this market while East European region is also growing
significantly. Increasing cases of drug allergies are one of the major factors
for the growth of the Europe market.
Asia Pacific region is showing the fastest growth rate in
the global drug allergy market due to some major factors such as increasing
awareness about various drug allergies, availability of treatment products, and
rapidly improving healthcare facilities. Japan is holding the major market
share while China’s drug allergy market is expected to show the fastest growth
in this region. Changing healthcare practices and increasing patient
involvement play an important role in the growth of this market.
The Middle East & Africa is expected to experience a
limited growth due to lack of awareness about diseases, traditional healthcare
practices, etc. The Middle East region dominates the market due to some of the
major factors, for instance, developed healthcare facilities and government
support to improve public health.
Browse
more Pharmaceutical Reports @ https://www.marketresearchfuture.com/categories/pharmaceutical-market-report
